ginkgolide b has been researched along with Cancer of Ovary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cong, Q; Edwards, D; Jiang, W; Qiu, W; Wang, Y; Xu, C; Ye, B | 1 |
| Cong, Q; Jiang, W; Wang, Y; Xu, C; Ye, B | 1 |
| Aponte, M; Cramer, DW; Dai, Y; Edwards, D; Ho, MC; Huang, TN; Li, L; Vitonis, A; Ye, B | 1 |
3 other study(ies) available for ginkgolide b and Cancer of Ovary
| Article | Year |
|---|---|
Ginkgo may prevent genetic-associated ovarian cancer risk: multiple biomarkers and anticancer pathways induced by ginkgolide B in BRCA1-mutant ovarian epithelial cells.
Topics: Cell Line, Transformed; Cell Proliferation; DNA Damage; Epithelial Cells; Female; Genes, BRCA1; Genetic Markers; Ginkgolides; Humans; Lactones; Mutation; Ovarian Neoplasms; Signal Transduction | 2011 |
Ginkgo May Sensitize Ovarian Cancer Cells to Cisplatin: Antiproliferative and Apoptosis-Inducing Effects of Ginkgolide B on Ovarian Cancer Cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Female; Flow Cytometry; Ginkgo biloba; Ginkgolides; Humans; Lactones; Ovarian Neoplasms | 2014 |
Ginkgo biloba and ovarian cancer prevention: epidemiological and biological evidence.
Topics: Case-Control Studies; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chromatography, Liquid; Cystadenocarcinoma, Mucinous; Dose-Response Relationship, Drug; Female; Ginkgo biloba; Ginkgolides; Humans; Lactones; Logistic Models; Mass Spectrometry; Massachusetts; New Hampshire; Ovarian Neoplasms; Phytotherapy; Plant Extracts; Quercetin | 2007 |